knowledge -WSS

knowledge

author：fashion 2025-09-30 21:58:06 - browse：389

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them. We also discuss the approval of Eli Lilly’s curiously named treatment for obesity, the latest implosion for a promising biotech company, and some news in the world of shareholder activism.

For more on what we cover, here’s the radiopharmaceuticals story; here’s the news on Lilly; here’s more on Ventyx Biosciences; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Peter Hotez and the public health issue of online harassment
Next article： The lessons of Aduhelm, an Alzheimer's drug that was not to be

focus

WSS

Eli Lilly’s chief scientist on obesity drugs, gene editing, and more

The real point of Kenneth Smith’s execution by nitrogen gas

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

What health policies could hitch a ride on a spending bill?

Do digital therapeutics have a future in medicine?

Study suggests Covid rebound is far more common with Paxlovid than without

hotspot

knowledge

Wikipedia

Trump demands the U.S. pay no more for drugs than other countries … again

New Ultima Genomics DNA sequencer can read genome for $100

Novavax promises a turnaround & Lilly roils the obesity market

Medicare’s new pay boost for primary care is angering specialists

Medicare details structure of new drug price negotiation program

Quicker fix for pulse oximeters urged during FDA public meeting

After affirmative action ruling, medical educators look to 'holistic review'

Cybersecurity threat forces Lurie Children's to take systems offline

In age of alternative facts, a scholarly course on calling out crap

Some dementia cases could be undiagnosed liver disease

leisure time

Experimental asthma app from Apple and Anthem shows promise

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Type 2 diabetes prevention programs work at large scale: study

Weight loss drugs should be covered by insurers, AMA says

Medicare drug price negotiation’s day in court

Quicker fix for pulse oximeters urged during FDA public meeting

knowledge

focus

Wikipedia

focus